GO:0016997 alpha-sialidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016997 (alpha-sialidase activity) is a molecular function defined as the catalysis of hydrolysis of alpha-glycosidic linkages in oligo- or poly(sialic) acids.
• Human exo-alpha-sialidases (neuraminidases) are well-characterized enzymes with distinct subcellular localizations and substrate specificities.
• Bacterial alpha-sialidases from Bifidobacterium bifidum, Bifidobacterium breve, and Bacteroides fragilis degrade sialylated oligosaccharides and can also synthesize sialylated products [1,3,4].
• Alpha-sialidase activity is critical for polysialic acid (PSA) turnover, affecting synaptic plasticity and choline acetyltransferase activity [7,8].
• Pathogens such as Clostridium perfringens and Corynebacterium pseudotuberculosis encode sialidases as virulence factors [5,6].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of alpha-sialidase function in health and disease.
Description
Alpha-sialidase activity (GO:0016997) is a molecular function that removes terminal sialic acid residues from oligo- and polysialic acids by hydrolyzing alpha-glycosidic linkages. This enzymatic activity is widely distributed across organisms, from bacteria to humans, and plays essential roles in glycan catabolism, cell-cell recognition, and host-pathogen interactions [2,3]. In humans, exo-alpha-sialidases (neuraminidases) are classified into several types with distinct subcellular localizations and substrate preferences. Bacterial alpha-sialidases, such as those from Bifidobacterium bifidum and Bacteroides fragilis, are involved in the degradation of sialylated human milk oligosaccharides and intestinal glycoconjugates, and some exhibit bifunctional properties including esterase activity [1,3,4]. Understanding alpha-sialidase activity is crucial for researchers studying glycobiology, neurobiology, and infectious diseases, as it impacts processes ranging from synaptic plasticity to pathogen virulence [5,6,7,8].
alpha-sialidase activity At A Glance
| GO ID | GO:0016997 |
|---|---|
| GO term | alpha-sialidase activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Catalysis of the hydrolysis of alpha-glycosidic linkages in oligo- or poly(sialic) acids. |
| Major function | Removal of terminal sialic acid residues from sialylated glycans. |
| EC number | 3.2.1.18 (exo-alpha-sialidase) |
| Representative enzymes | Human NEU1, NEU2, NEU3, NEU4; bacterial sialidases from Bifidobacterium, Bacteroides, Clostridium. |
| Substrates | Sialyllactose, sialylated oligosaccharides, polysialic acid (PSA), glycoproteins, glycolipids. |
What Is GO:0016997?
Alpha-sialidase activity (GO:0016997) is defined as the catalysis of the hydrolysis of alpha-glycosidic linkages in oligo- or poly(sialic) acids. This means the enzyme cleaves the bond between a terminal sialic acid and the underlying sugar or another sialic acid unit, releasing free sialic acid. The term encompasses exo-alpha-sialidases that act on the non-reducing end of sialylated glycans, and it is distinct from endo-sialidases that cleave internally. The activity is found in diverse organisms and is essential for the turnover of sialylated molecules such as polysialic acid (PSA) on neural cell adhesion molecule (NCAM) [7,8].
Why Is alpha-sialidase activity Important in Cell Biology?
Alpha-sialidase activity is fundamental to the regulation of sialic acid metabolism, which influences a wide array of biological processes including cell signaling, immune recognition, and neural development [2,7,8]. Dysregulation of sialidases has been linked to lysosomal storage disorders, cancer progression, and pathogen virulence [2,5,6]. In the brain, polysialic acid (PSA) on NCAM is required for activity-induced synaptic plasticity, and its removal by sialidases modulates choline acetyltransferase activity induced by brain-derived neurotrophic factor [7,8]. Thus, understanding alpha-sialidase activity provides insights into both normal physiology and disease mechanisms.
• Regulates turnover of polysialic acid (PSA) on NCAM, affecting synaptic plasticity and memory formation.
• Modulates choline acetyltransferase activity in response to BDNF, impacting cholinergic neuron function.
• Enables gut bacteria to degrade sialylated human milk oligosaccharides, influencing infant nutrition and microbiome development [3,4].
• Contributes to pathogen virulence, as seen in Clostridium perfringens and Corynebacterium pseudotuberculosis [5,6].
• Involved in lysosomal catabolism of sialoglycoconjugates; defects cause sialidosis and related disorders.
• Plays a role in cancer metastasis by altering cell surface sialylation.
• Provides targets for antiviral and antibacterial drug development [2,5].
• Facilitates enzymatic synthesis of sialylated oligosaccharides like 6'-sialyllactose.
• Serves as a model for studying glycoside hydrolase mechanism and specificity [1,2].
• Enables production of sialylated compounds for food and pharmaceutical applications.
What Happens During alpha-sialidase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs onto a sialic acid-containing sugar chain.
Alpha-sialidases recognize terminal sialic acid residues on oligo- or polysialic acids. The enzyme binds to the substrate through a combination of hydrogen bonding and hydrophobic interactions, positioning the alpha-glycosidic linkage for cleavage. Bacterial sialidases often have carbohydrate-binding modules that enhance substrate affinity [1,3].
Catalytic hydrolysis
In simple terms: The enzyme cuts the bond between sialic acid and the rest of the sugar chain.
The catalytic mechanism involves a conserved arginine triad and a tyrosine residue that stabilize the sialic acid moiety during hydrolysis. The enzyme uses an acid-base catalysis mechanism, often with a conserved aspartate or glutamate as the nucleophile, to cleave the alpha-glycosidic bond, releasing free sialic acid and the desialylated glycan.
Product release and enzyme turnover
In simple terms: After cutting, the enzyme lets go of the products and is ready to act again.
Following hydrolysis, the enzyme releases the free sialic acid and the remaining glycan. The active site is then free to bind another substrate molecule. Some sialidases exhibit trans-sialidase activity, transferring sialic acid to an acceptor rather than water, as seen in certain bacterial enzymes [1,4].
Regulation by pH and localization
In simple terms: The enzyme works best in specific cellular locations and pH conditions.
Human sialidases have distinct pH optima and subcellular localizations: NEU1 is lysosomal, NEU2 is cytosolic, NEU3 is plasma membrane-associated, and NEU4 is mitochondrial/lysosomal. These differences dictate their substrate access and physiological roles.
Key Genes Involved in GO:0016997 alpha-sialidase activity
The following genes encode enzymes with alpha-sialidase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NEU1 | Lysosomal exo-alpha-sialidase; cleaves sialic acid from glycoproteins and oligosaccharides | Mutations cause sialidosis; studied for lysosomal storage disorders |
| NEU2 | Cytosolic sialidase; involved in ganglioside metabolism | Implicated in cancer and muscle differentiation |
| NEU3 | Plasma membrane sialidase; specifically hydrolyzes gangliosides | Overexpressed in various cancers; target for cancer research |
| NEU4 | Mitochondrial/lysosomal sialidase; broad substrate specificity | Linked to neuronal differentiation and apoptosis |
| Bifidobacterium bifidum sialidase | Bifunctional sialidase with esterase activity; degrades sialyloligosaccharides | Probiotic applications; infant gut health |
| Bifidobacterium breve sialidase | Exo-alpha-sialidase involved in degradation of sialyloligosaccharides in human milk | Microbiome and infant nutrition research |
| Bacteroides fragilis sialidase | Exo-alpha-sialidase used for enzymatic synthesis of 6'-sialyllactose | Biocatalysis and oligosaccharide production |
| Clostridium perfringens sialidase | Virulence factor; degrades host sialylated glycans | Pathogenesis and antibiotic resistance studies |
| Corynebacterium pseudotuberculosis sialidase | Potential virulence factor in ovine and caprine strains | Veterinary microbiology and vaccine development |
| PSA-NCAM | Polysialic acid on NCAM; substrate for sialidases | Synaptic plasticity and brain development |
| ChAT | Choline acetyltransferase; activity modulated by PSA and BDNF | Cholinergic neuron function and neurodegeneration |
| BDNF | Brain-derived neurotrophic factor; regulates ChAT via PSA | Neurotrophin signaling and synaptic plasticity |
| NanH | Sialidase from Clostridium perfringens | Virulence and enzyme mechanism |
| SiaA | Sialidase from Corynebacterium pseudotuberculosis | Pathogen adaptation |
| Sialidase A | Bifidobacterium bifidum enzyme with esterase activity | Bifunctional enzyme studies |
| Sialidase B | Bifidobacterium breve enzyme | Human milk oligosaccharide utilization |
| BfSia | Bacteroides fragilis sialidase | Synthetic biology and glycoengineering |
How Is alpha-sialidase activity Regulated?
Alpha-sialidase activity is regulated at multiple levels. Human sialidases are differentially expressed and localized, with NEU1 requiring association with protective protein/cathepsin A (PPCA) for activity and stability. NEU3 is activated by growth factors and oncogenic signaling, while NEU4 is regulated during differentiation. In bacteria, sialidase expression is often induced by sialic acid availability and subject to catabolite repression [3,4]. Additionally, polysialic acid (PSA) turnover by sialidases is modulated by neural activity and neurotrophins such as BDNF, which influences choline acetyltransferase activity.
alpha-sialidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NEU1 | Sialidosis; lysosomal storage disorder | NEU1 knockout mice; patient-derived fibroblasts |
| NEU3 | Cancer progression; metastasis | NEU3 overexpression in cancer cell lines; xenograft models |
| PSA-NCAM | Synaptic plasticity; memory formation | PSA-NCAM knockout mice; electrophysiology |
| ChAT | Cholinergic neuron function; neurodegeneration | ChAT reporter mice; BDNF treatment |
| Clostridium perfringens sialidase | Virulence; gas gangrene | Mouse infection models; sialidase inhibitors |
Sialidosis and lysosomal storage disorders
Mutations in NEU1 cause sialidosis, a lysosomal storage disorder characterized by accumulation of sialylated glycoconjugates, leading to progressive neurological deterioration, myoclonus, and cherry-red spots. Defects in NEU1 also underlie galactosialidosis when PPCA is deficient.
Cancer progression and metastasis
Altered sialidase expression, particularly NEU3 overexpression, is associated with various cancers including colon, ovarian, and renal cell carcinomas. NEU3 promotes cell survival and migration by modulating ganglioside metabolism and cell surface sialylation.
Bacterial pathogenesis
Sialidases from Clostridium perfringens and Corynebacterium pseudotuberculosis contribute to virulence by degrading host sialylated glycans, facilitating tissue invasion and immune evasion [5,6]. These enzymes are potential targets for antimicrobial therapy.
Neurological disorders and synaptic dysfunction
Polysialic acid (PSA) on NCAM is essential for synaptic plasticity, and its removal by sialidases affects learning and memory. Dysregulation of PSA turnover has been implicated in schizophrenia and neurodegenerative conditions [7,8].
From alpha-sialidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NEU1 loss cause lysosomal accumulation? | NEU1 knockout cell lines (e.g., HEK293, fibroblasts) |
| How does NEU3 point mutation affect ganglioside binding? | CRISPR point mutation knock-in of NEU3 in cancer cells |
| Can bacterial sialidase be used for 6'-sialyllactose synthesis? | Overexpression of Bacteroides fragilis sialidase in E. coli |
| What is the role of PSA-NCAM in synaptic plasticity? | PSA-NCAM knockout mice; electrophysiology |
| How does BDNF regulate ChAT via PSA? | BDNF-treated neuronal cultures; sialidase inhibition |
| Is sialidase a virulence factor in C. pseudotuberculosis? | Sialidase knockout in Corynebacterium pseudotuberculosis; infection model |
How to Study the alpha-sialidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic sialidase assay | Enzyme activity using MU-Neu5Ac | Kinetic characterization of purified sialidases |
| LC-MS/MS glycomics | Sialylated glycan structures | Substrate specificity and product analysis [1,4] |
| CRISPR knockout screen | Genes affecting sialidase activity or sialylation | Identification of regulatory pathways |
| Flow cytometry with lectins | Cell surface sialic acid levels | Sialidase treatment on live cells |
| Western blot | Protein expression of sialidases | Validation of knockout or overexpression |
| Immunohistochemistry | Tissue localization of sialidases | Neural tissue and tumor sections [7,8] |
| Enzymatic synthesis | Production of sialylated oligosaccharides | Biocatalysis for 6'-sialyllactose |
| Mouse behavioral tests | Synaptic plasticity and memory | PSA-NCAM knockout studies |
Enzymatic activity assays
Alpha-sialidase activity is commonly measured using fluorogenic substrates such as 4-methylumbelliferyl-N-acetylneuraminic acid (MU-Neu5Ac) or chromogenic substrates. These assays quantify the release of sialic acid and are used to characterize enzyme kinetics, pH optima, and inhibitor sensitivity [2,3].
Glycan analysis by mass spectrometry
Mass spectrometry (e.g., MALDI-TOF, LC-MS/MS) is used to profile sialylated glycans and monitor desialylation by alpha-sialidases. This method provides structural information on substrate specificity and product formation [1,4].
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate alpha-sialidase activity or sialylation pathways. Such screens have been used to uncover modifiers of sialic acid metabolism and host-pathogen interactions.
Imaging and flow cytometry
Fluorescently labeled sialic acid analogs or lectins (e.g., Sambucus nigra agglutinin) can visualize cell surface sialylation and its removal by sialidases. Flow cytometry enables quantitative assessment of sialidase activity on live cells [7,8].
How CRISPR Can Be Used to Study GO:0016997 alpha-sialidase activity
Knockout
CRISPR-Cas9 knockout of sialidase genes (e.g., NEU1, NEU3) in cell lines or animal models enables loss-of-function studies to determine their role in glycan turnover, lysosomal function, and cancer progression. Knockout of bacterial sialidases in Clostridium perfringens or Corynebacterium pseudotuberculosis can assess their contribution to virulence [5,6].
Point Mutation
Introducing specific point mutations in catalytic residues (e.g., arginine triad, tyrosine) of alpha-sialidases via CRISPR base editing or homology-directed repair allows precise dissection of enzymatic mechanism and substrate specificity. Such models are valuable for studying disease-associated mutations in NEU1.
Knock-in
Knock-in of tagged sialidase alleles (e.g., FLAG, GFP) using CRISPR facilitates localization, interaction, and trafficking studies. Knock-in of human sialidase genes into model organisms can humanize pathways for drug testing [2,4].
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of sialidases (e.g., NEU3, bacterial sialidases) is used to study gain-of-function effects, including oncogenic transformation, enhanced glycan degradation, and enzymatic synthesis of sialylated products [2,4].
How EDITGENE Supports alpha-sialidase activity Research
Researchers studying alpha-sialidase activity-related genes often need to determine whether a candidate gene is causally involved in sialic acid metabolism, disease progression, or host-pathogen interactions. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of sialidase genes and their regulatory networks.
Contact EDITGENE today to design your custom CRISPR model for alpha-sialidase activity research.
Frequently Asked Questions About alpha-sialidase activity
What is alpha-sialidase activity?
Alpha-sialidase activity (GO:0016997) is the catalysis of hydrolysis of alpha-glycosidic linkages in oligo- or poly(sialic) acids, removing terminal sialic acid residues.
What genes are involved in alpha-sialidase activity?
Key genes include human NEU1, NEU2, NEU3, NEU4, and bacterial sialidases from Bifidobacterium, Bacteroides, Clostridium, and Corynebacterium species [1,2,3,4,5,6].
What diseases are associated with alpha-sialidase activity?
Mutations in NEU1 cause sialidosis; NEU3 overexpression is linked to cancer; bacterial sialidases contribute to virulence in Clostridium perfringens and Corynebacterium pseudotuberculosis [2,5,6].
How is alpha-sialidase activity measured?
Common methods include fluorogenic assays with MU-Neu5Ac, mass spectrometry of glycans, and lectin-based flow cytometry [2,3,4].
What is the role of alpha-sialidase in the brain?
It regulates polysialic acid (PSA) turnover on NCAM, affecting synaptic plasticity and choline acetyltransferase activity [7,8].
Can alpha-sialidases be used for enzymatic synthesis?
Yes, Bacteroides fragilis sialidase has been used to synthesize 6'-sialyllactose, a dominant sialylated human milk oligosaccharide.
What are the different types of human sialidases?
Human sialidases include NEU1 (lysosomal), NEU2 (cytosolic), NEU3 (plasma membrane), and NEU4 (mitochondrial/lysosomal), each with distinct substrate specificities.
How do CRISPR knockouts help study alpha-sialidase activity?
CRISPR knockout of sialidase genes enables loss-of-function studies to determine their roles in glycan metabolism, disease, and pathogen virulence [2,5,6].
What is the difference between alpha-sialidase and neuraminidase?
Alpha-sialidase and neuraminidase are often used interchangeably for exo-alpha-sialidases that cleave terminal sialic acid; however, neuraminidase can also refer to viral enzymes with similar activity.
What substrates do alpha-sialidases act on?
Substrates include sialyllactose, sialylated oligosaccharides, polysialic acid (PSA), glycoproteins, and glycolipids [2,3,4,7].
Conclusion
Alpha-sialidase activity (GO:0016997) is a fundamental enzymatic function that regulates sialic acid metabolism across diverse biological contexts, from bacterial nutrient acquisition to human neural development and disease. The availability of CRISPR-based tools for precise genetic manipulation of sialidase genes, combined with advanced glycomic and enzymatic assays, empowers researchers to dissect the mechanistic roles of these enzymes in health and disease [2,7,8]. EDITGENE's comprehensive cell model and screening services support these efforts, enabling the generation of publication-ready data for glycobiology and drug discovery.
References
- 1. Ashida H et al.. 2018. Bifunctional properties and characterization of a novel sialidase with esterase activity from Bifidobacterium bifidum.. Biosci Biotechnol Biochem 82(11):2030-2039 PMID: 30027820
- 2. Achyuthan KE et al.. 2001. Comparative enzymology, biochemistry and pathophysiology of human exo-alpha-sialidases (neuraminidases).. Comp Biochem Physiol B Biochem Mol Biol 129(1):29-64 PMID: 11337249
- 3. Kiyohara M et al.. 2011. An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates.. Glycobiology 21(4):437-47 PMID: 21036948
- 4. Guo L et al.. 2018. Enzymatic Synthesis of 6'-Sialyllactose, a Dominant Sialylated Human Milk Oligosaccharide, by a Novel exo-α-Sialidase from Bacteroides fragilis NCTC9343.. Appl Environ Microbiol 84(13) PMID: 29678922
- 5. AlJindan R et al.. 2023. Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A.. Toxins (Basel) 15(6) PMID: 37368661
- 6. Markova J et al.. 2024. Ovine and Caprine Strains of Corynebacterium pseudotuberculosis on Czech Farms-A Comparative Study.. Microorganisms 12(5) PMID: 38792705
- 7. Muller D et al.. 1996. PSA-NCAM is required for activity-induced synaptic plasticity.. Neuron 17(3):413-22 PMID: 8816705
- 8. Burgess A et al.. 2006. Polysialic acid limits choline acetyltransferase activity induced by brain-derived neurotrophic factor.. J Neurochem 99(3):797-806 PMID: 16903870
